Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36442525)

  • 1. ARD1 stabilizes NRF2 through direct interaction and promotes colon cancer progression.
    Fang X; Lee YH; Jang JH; Kim SJ; Kim SH; Kim DH; Na HK; Kim KO; Baek JH; Surh YJ
    Life Sci; 2023 Jan; 313():121217. PubMed ID: 36442525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells.
    Jung KA; Kwak MK
    Oxid Med Cell Longev; 2013; 2013():423965. PubMed ID: 23766854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
    Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
    Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
    Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
    Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
    Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.
    Tian Y; Wu K; Liu Q; Han N; Zhang L; Chu Q; Chen Y
    J Hematol Oncol; 2016 Sep; 9(1):83. PubMed ID: 27601007
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
    Zeng H; Zhao X; Tang C
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):223-233. PubMed ID: 33907880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
    Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer.
    Ren T; Jiang B; Jin G; Li J; Dong B; Zhang J; Meng L; Wu J; Shou C
    Cancer Lett; 2008 Jun; 264(1):83-92. PubMed ID: 18325661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
    Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
    Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF.
    Bilton R; Mazure N; Trottier E; Hattab M; Déry MA; Richard DE; Pouysségur J; Brahimi-Horn MC
    J Biol Chem; 2005 Sep; 280(35):31132-40. PubMed ID: 15994306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
    Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
    Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Danilovic DLS; de Mello ES; Frazzato EST; Wakamatsu A; de Lima Jorge AA; Hoff AO; Marui S
    Head Neck; 2018 Jun; 40(6):1271-1278. PubMed ID: 29469959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations.
    Cheng L; Wang H; Li S; Liu Z; Wang C
    Life Sci; 2021 Oct; 282():119791. PubMed ID: 34229009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells.
    Li CQ; Kim MY; Godoy LC; Thiantanawat A; Trudel LJ; Wogan GN
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14547-51. PubMed ID: 19706542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.